SR 142948A
SIGMA/SML0015 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 184162-21-8
Empirical Formula (Hill Notation): C39H51N5O6·HCl
Molecular Weight: 722.31
MDL Number: MFCD03106502
Linear Formula: C39H51N5O6·HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C39H51N5O6.ClH/c1-23(2 |
| InChI key | CUYNEHGBVHUQQW-BVJGGMLGSA |
| originator | Sanofi Aventis |
| Quality Level | 100 ![]() |
| SMILES string | Cl.COc1cccc(OC)c1-c2cc(nn |
| solubility | H2O: ≥2 mg/mL at warmed to 60 °C |
| storage temp. | 2-8°C |
| Application: | SR 142948A was used to study the role of neurotensin signaling in intracellular alkanization and expression of IL-8 in human pancreatic cancer cells. |
| Biochem/physiol Actions: | SR 142948A is a neurotensin receptor antagonist |
| Biochem/physiol Actions: | SR 142948A is a non-peptide Neurotensin receptor antagonist |
| Biochem/physiol Actions: | SR 142948A is a potent neurotensin receptor antagonist that affects the expression of c-Fos and has properties of antipsychotic agent. It blocks hypothermia and analgesia induced by neurotensin. It blocks the increase in the concentration of Ca+2 induced by the activation of phospholipase C in CHO cell model. |
| Features and Benefits: | This compound is featured on the Neurotensin Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Sanofi Aventis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

